Wuxi Biologics (Cayman) Inc(WXXWY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

WXXWY Wuxi Biologics (Cayman) Inc

Pre-Market Trading 11-14 16:00:00 EST Delay

{"stockData":{"symbol":"WXXWY","market":"US","secType":"STK","nameCN":"Wuxi Biologics (Cayman) Inc","latestPrice":3.82,"timestamp":1731618000000,"preClose":4.01,"halted":0,"volume":184362,"delay":15,"floatShares":1752522441,"shares":2052110457,"eps":0.165102,"marketStatus":"Pre-Market Trading","change":-0.19,"latestTime":"11-14 16:00:00 EST Delay","open":3.84,"high":3.86,"low":3.8,"amount":706951.4898999999,"amplitude":0.014963,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.165102,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1731681000000},"marketStatusCode":1,"adr":0,"adrRate":2,"exchange":"PINK","adjPreClose":3.82,"volumeRatio":5.2390451966898},"requestUrl":"/m/hq/s/WXXWY/tweets","defaultTab":"tweets","newsList":[{"id":"2473993581","title":"Chinese biotechs gain as drugmakers targeted in new security bill said to mull divestments","url":"https://stock-news.laohu8.com/highlight/detail?id=2473993581","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2473993581?lang=en_us&edition=fundamental","pubTime":"2024-10-05 01:55","pubTimestamp":1728064511,"startTime":"0","endTime":"0","summary":"WuXi AppTec (OTCPK:WUXIF) and WuXi Biologics (OTCPK:WXIBF), two affiliated China-based drugmakers targeted in recent national security legislation, are seeking to sell some of their assets in the U.S.","market":"sg","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1417030992/image_1417030992.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1417030992/image_1417030992.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4156530-chinese-firms-targeted-new-security-bill-mull-divestments","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["WXIBF","WUXIF","BK4504","BK4505","BK4526","WXXWY","BK4121","BK4535","BK4585","BK4588","BK4548","BGNE","BK4139"],"gpt_icon":0},{"id":"2470709866","title":"WuXi Biologics: Consider Proposed Legislation And Financial Prospects","url":"https://stock-news.laohu8.com/highlight/detail?id=2470709866","media":"seekingalpha","labels":["analysis"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2470709866?lang=en_us&edition=fundamental","pubTime":"2024-09-27 17:42","pubTimestamp":1727430166,"startTime":"0","endTime":"0","summary":"I award a Hold rating to WuXi Biologics after evaluating the impact of the draft bill for the Biosecure Act and the company's financial outlook for the current year.The grandfather clause in the draft","market":"nz","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2158228359/image_2158228359.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2158228359/image_2158228359.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4723661-wuxi-biologics-consider-proposed-legislation-financial-prospects","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"analysis","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["WXIBF","WXXWY","BK4121"],"gpt_icon":0},{"id":"2461809500","title":"Wuxi Biologics ADR Non-GAAP EPS of RMB0.52, revenue of RMB8.57M","url":"https://stock-news.laohu8.com/highlight/detail?id=2461809500","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2461809500?lang=en_us&edition=fundamental","pubTime":"2024-08-22 04:28","pubTimestamp":1724272134,"startTime":"0","endTime":"0","summary":"Wuxi Biologics ADR press release  (OTCPK:WXXWY): 1H  Non-GAAP EPS of RMB0.52.\nRevenue of RMB8.57M.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4142555-wuxi-biologics-adr-non-gaap-eps-of-rmb052-revenue-of-rmb857m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["BK4121","WXXWY"],"gpt_icon":0},{"id":"2459207054","title":"AMR Update - Mid-2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2459207054","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2459207054?lang=en_us&edition=fundamental","pubTime":"2024-08-15 21:47","pubTimestamp":1723729656,"startTime":"0","endTime":"0","summary":"The first reason is exposure to small caps and the second is exposure to healthcare. I also have tossed in a healthy dose of selling winners and buying losers over the past few months, so many have yet to re-find all-time highs. It is also important","market":"nz","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1904939586/image_1904939586.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1904939586/image_1904939586.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4714814-amr-update-mid-2024","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["XMTR","RGEN","BK4504","BK4581","SPXU","ARIS","BMY","CSHI","SGIOY","HXGBY","BWMX","AME","SSO","CDZI","WXXWY","JLL","LU0640476718.USD","TECH","IE00B4R5TH58.HKD","EOSE","NJDCY","OEX","ASPN","AMR","OEF","PATH","BRKR","MEG","NET","TRC","SPY","DSCSY","BK4505","LU1064131342.USD","SDS","VOO","CDMO","DAVA","IVV","SH","IE00BFTCPJ56.SGD",".SPX","ESmain","HLI","SITE"],"gpt_icon":1},{"id":"2451526519","title":"The Good And The Bad For WuXi Biologics","url":"https://stock-news.laohu8.com/highlight/detail?id=2451526519","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2451526519?lang=en_us&edition=fundamental","pubTime":"2024-07-16 13:12","pubTimestamp":1721106768,"startTime":"0","endTime":"0","summary":"The good things to note about WXIBF is that the outlook for biotech funding is favorable, considering expectations of a rate cut this year, and the stock's potential buyback yield is appealing.The bad","market":"nz","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1369987284/image_1369987284.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1369987284/image_1369987284.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4704209-the-good-and-the-bad-for-wuxi-biologics","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["WXIBF","WUXAY","WXXWY","BK4121","WUXIF"],"gpt_icon":0},{"id":"2441574122","title":"Medpace: Clear Winner If China Blockade Succeeds","url":"https://stock-news.laohu8.com/highlight/detail?id=2441574122","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2441574122?lang=en_us&edition=fundamental","pubTime":"2024-06-05 04:12","pubTimestamp":1717531956,"startTime":"0","endTime":"0","summary":"Medpace Holdings is a US-based clinical research organization that is well-positioned to benefit from increased demand due to geopolitical risks affecting Chinese firms.Medpace stands out among its pe","market":"fut","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/164662512/image_164662512.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/164662512/image_164662512.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4697415-medpace-clear-winner-if-china-blockade-succeeds","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["LU2125909759.SGD","LU1548497426.USD","LU0310800379.SGD","LU0011850046.USD","LU0198837287.USD","IQV","LU0557290698.USD","LU1983260115.SGD","LU1791710582.SGD","LU0114720955.EUR","LU1854104046.USD","LU0289961442.SGD","BK4530","LU1791710400.SGD","LU1670627923.USD","LU1064131342.USD","BK4588","LU0957791311.USD","LU1923622291.USD","LU2125910179.SGD","LU1623119135.USD","MEDP","LU1670628061.USD","LU2125909916.SGD","CRL","FUJIY","LU1854103824.USD","LZAGY","LU2125910336.SGD","LU2063271972.USD","ICLR","BK4170","LU1720051108.HKD","IE00B2B36J28.USD","LU1720051017.SGD","LU2265009873.SGD","LU1923622614.USD","TMO","BK4566","LU0980610538.SGD","BK4585","LU1712237335.SGD","WXXWY","LU0175139822.USD","LU0390134368.USD","CTLT","LU0289739343.SGD","IE0009355771.USD","LU0640476718.USD","IE00BFTCPJ56.SGD"],"gpt_icon":0},{"id":"2439026577","title":"Harding Loevner Emerging Markets Equity Composite Q1 2024 Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2439026577","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2439026577?lang=en_us&edition=fundamental","pubTime":"2024-05-30 00:00","pubTimestamp":1716998400,"startTime":"0","endTime":"0","summary":"Click to enlarge Source: FactSet, MSCI Inc. Data as of March 31, 2024. In its domestic economy, China’s real-estate market continued to falter, and the recovery in consumption remained muted despite ongoing policy support. The manufacturing sector showed signs of strength, with industrial production rising 7% in January and February from a year ago and ind","market":"hk","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1296098015/image_1296098015.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1296098015/image_1296098015.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4696244-harding-loevner-emerging-markets-equity-composite-q1-2024-report","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["BUGDF","LU0588546209.SGD","BK4581","TCOM","MELI","NHNCF","GLOB","LU2265009873.SGD","TSM","LU2063271972.USD","09988","LU0307460666.USD","AAIGF","IT","ASML","BK4592","PCCYF","TRPCF","IE00BMPRXN33.USD","LU2125154778.USD","WUXIF","LOOP","EQR","03145","HDB","LU0052756011.USD","SSNLF","LU1242518931.SGD","BK4591","LU1282649067.USD","WXXWY","SG9999004220.SGD","GB","LU0708995583.HKD","BK4588","LU1064131342.USD","KOF","BK4587","LU0516422366.SGD","LU0198837287.USD","AAGIY","AMZN","WMT","03165","WUXAY","BK4585","BUHPF","BK4575","WXIBF","BK4579"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.wuxibiologics.com","stockEarnings":[{"period":"1week","weight":0.0455},{"period":"1month","weight":0.056},{"period":"3month","weight":0.1404},{"period":"6month","weight":0.0218},{"period":"1year","weight":0.2475},{"period":"ytd","weight":0.6829}],"description":"WuXi Biologics (Cayman) Inc is an investment holding company principally engaged in the provision of end-to-end solutions and services for biologics discovery, development and manufacturing to customers involving in biologics industry. The Company mainly operates its business through two segments. The Biologics segment mainly engages in the provision of biologics discovery, development and manufacturing. The WuXi XDC (XDC) segment mainly engages in the provision of contract research, development and manufacturing organization (CRDMO) services for antibody-drug conjugate (ADCs) and various bioconjugates. The Company mainly conducts its business in the domestic and overseas markets.","exchange":"PINK","name":"Wuxi Biologics (Cayman) Inc","nameEN":"Wuxi Biologics (Cayman) Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Wuxi Biologics (Cayman) Inc(WXXWY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Wuxi Biologics (Cayman) Inc(WXXWY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Wuxi Biologics (Cayman) Inc,WXXWY,Wuxi Biologics (Cayman) Inc股票,Wuxi Biologics (Cayman) Inc股票老虎,Wuxi Biologics (Cayman) Inc股票老虎国际,Wuxi Biologics (Cayman) Inc行情,Wuxi Biologics (Cayman) Inc股票行情,Wuxi Biologics (Cayman) Inc股价,Wuxi Biologics (Cayman) Inc股市,Wuxi Biologics (Cayman) Inc股票价格,Wuxi Biologics (Cayman) Inc股票交易,Wuxi Biologics (Cayman) Inc股票购买,Wuxi Biologics (Cayman) Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Wuxi Biologics (Cayman) Inc(WXXWY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Wuxi Biologics (Cayman) Inc(WXXWY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction